Clinical trial
Monitoring Anti-Dementia Drugs by Serum Levels: Importance of Serum Levels, Drug-monitoring, Side-effects, Clinical Efficacy and Compliance (Translation of Official Danish Title)
NCT04117178 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring Anti-Dementia Drugs by Serum Levels: Importance of Serum Levels, Drug-monitoring, Side-effects, Clinical Efficacy and Compliance (Translation of Official Danish Title)
- Lead sponsor
- Zealand University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 4, 2020
- Completion date
- February 16, 2023
- Enrollment
- 132 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, dementia, dementia alzheimers, dementia in parkinsons disease, dementia with lewy bodies